117 related articles for article (PubMed ID: 28609096)
1. Identification and Profiling of a Selective and Brain Penetrant Radioligand for in Vivo Target Occupancy Measurement of Casein Kinase 1 (CK1) Inhibitors.
Wager TT; Galatsis P; Chandrasekaran RY; Butler TW; Li J; Zhang L; Mente S; Subramanyam C; Liu S; Doran AC; Chang C; Fisher K; Grimwood S; Hedde JR; Marconi M; Schildknegt K
ACS Chem Neurosci; 2017 Sep; 8(9):1995-2004. PubMed ID: 28609096
[TBL] [Abstract][Full Text] [Related]
2. Casein kinase 1δ/ε inhibitor PF-5006739 attenuates opioid drug-seeking behavior.
Wager TT; Chandrasekaran RY; Bradley J; Rubitski D; Berke H; Mente S; Butler T; Doran A; Chang C; Fisher K; Knafels J; Liu S; Ohren J; Marconi M; DeMarco G; Sneed B; Walton K; Horton D; Rosado A; Mead A
ACS Chem Neurosci; 2014 Dec; 5(12):1253-65. PubMed ID: 25299732
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of casein kinase 1 epsilon minimally alters circadian clock period.
Walton KM; Fisher K; Rubitski D; Marconi M; Meng QJ; Sládek M; Adams J; Bass M; Chandrasekaran R; Butler T; Griffor M; Rajamohan F; Serpa M; Chen Y; Claffey M; Hastings M; Loudon A; Maywood E; Ohren J; Doran A; Wager TT
J Pharmacol Exp Ther; 2009 Aug; 330(2):430-9. PubMed ID: 19458106
[TBL] [Abstract][Full Text] [Related]
4. Casein Kinase 1δ Inhibitors as Promising Therapeutic Agents for Neurodegenerative Disorders.
Catarzi D; Varano F; Vigiani E; Lambertucci C; Spinaci A; Volpini R; Colotta V
Curr Med Chem; 2022; 29(27):4698-4737. PubMed ID: 35232339
[TBL] [Abstract][Full Text] [Related]
5. Autokinase Activity of Casein Kinase 1 δ/ε Governs the Period of Mammalian Circadian Rhythms.
Guo G; Wang K; Hu SS; Tian T; Liu P; Mori T; Chen P; Johnson CH; Qin X
J Biol Rhythms; 2019 Oct; 34(5):482-496. PubMed ID: 31392916
[TBL] [Abstract][Full Text] [Related]
6. p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs.
Knippschild U; Milne DM; Campbell LE; DeMaggio AJ; Christenson E; Hoekstra MF; Meek DW
Oncogene; 1997 Oct; 15(14):1727-36. PubMed ID: 9349507
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of gamma-secretase by the CK1 inhibitor IC261 does not depend on CK1delta.
Höttecke N; Liebeck M; Baumann K; Schubenel R; Winkler E; Steiner H; Schmidt B
Bioorg Med Chem Lett; 2010 May; 20(9):2958-63. PubMed ID: 20350806
[TBL] [Abstract][Full Text] [Related]
8. Gene expression levels of Casein kinase 1 (CK1) isoforms are correlated to adiponectin levels in adipose tissue of morbid obese patients and site-specific phosphorylation mediated by CK1 influences multimerization of adiponectin.
Xu P; Fischer-Posovszky P; Bischof J; Radermacher P; Wabitsch M; Henne-Bruns D; Wolf AM; Hillenbrand A; Knippschild U
Mol Cell Endocrinol; 2015 May; 406():87-101. PubMed ID: 25724478
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Inhibitor of Wnt Production 2 (IWP-2) and Related Compounds As Selective ATP-Competitive Inhibitors of Casein Kinase 1 (CK1) δ/ε.
García-Reyes B; Witt L; Jansen B; Karasu E; Gehring T; Leban J; Henne-Bruns D; Pichlo C; Brunstein E; Baumann U; Wesseler F; Rathmer B; Schade D; Peifer C; Knippschild U
J Med Chem; 2018 May; 61(9):4087-4102. PubMed ID: 29630366
[TBL] [Abstract][Full Text] [Related]
10. The period of the circadian oscillator is primarily determined by the balance between casein kinase 1 and protein phosphatase 1.
Lee HM; Chen R; Kim H; Etchegaray JP; Weaver DR; Lee C
Proc Natl Acad Sci U S A; 2011 Sep; 108(39):16451-6. PubMed ID: 21930935
[TBL] [Abstract][Full Text] [Related]
11. An inhibitor of casein kinase I epsilon induces phase delays in circadian rhythms under free-running and entrained conditions.
Badura L; Swanson T; Adamowicz W; Adams J; Cianfrogna J; Fisher K; Holland J; Kleiman R; Nelson F; Reynolds L; St Germain K; Schaeffer E; Tate B; Sprouse J
J Pharmacol Exp Ther; 2007 Aug; 322(2):730-8. PubMed ID: 17502429
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel protein kinase CK1 delta (CK1delta) inhibitors through structure-based virtual screening.
Cozza G; Gianoncelli A; Montopoli M; Caparrotta L; Venerando A; Meggio F; Pinna LA; Zagotto G; Moro S
Bioorg Med Chem Lett; 2008 Oct; 18(20):5672-5. PubMed ID: 18799313
[TBL] [Abstract][Full Text] [Related]
13. Targeting Casein Kinase 1 (CK1) in Hematological Cancers.
Janovská P; Normant E; Miskin H; Bryja V
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33261128
[TBL] [Abstract][Full Text] [Related]
14. Syntheses and evaluation of carbon-11- and fluorine-18-radiolabeled pan-tropomyosin receptor kinase (Trk) inhibitors: exploration of the 4-aza-2-oxindole scaffold as Trk PET imaging agents.
Bernard-Gauthier V; Aliaga A; Aliaga A; Boudjemeline M; Hopewell R; Kostikov A; Rosa-Neto P; Thiel A; Schirrmacher R
ACS Chem Neurosci; 2015 Feb; 6(2):260-76. PubMed ID: 25350780
[TBL] [Abstract][Full Text] [Related]
15. Development of dual casein kinase 1δ/1ε (CK1δ/ε) inhibitors for treatment of breast cancer.
Monastyrskyi A; Nilchan N; Quereda V; Noguchi Y; Ruiz C; Grant W; Cameron M; Duckett D; Roush W
Bioorg Med Chem; 2018 Feb; 26(3):590-602. PubMed ID: 29289448
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of casein kinase 1 δ/ε improves cognitive performance in adult C57BL/6J mice.
Mahoney H; Peterson E; Justin H; Gonzalez D; Cardona C; Stevanovic K; Faulkner J; Yunus A; Portugues A; Henriksen A; Burns C; McNeill C; Gamsby J; Gulick D
Sci Rep; 2021 Feb; 11(1):4746. PubMed ID: 33637777
[TBL] [Abstract][Full Text] [Related]
17. A novel consensus phosphorylation motif in sulfatide- and cholesterol-3-sulfate-binding protein substrates for CK1 in vitro.
Kawakami F; Suzuki K; Ohtsuki K
Biol Pharm Bull; 2008 Feb; 31(2):193-200. PubMed ID: 18239272
[TBL] [Abstract][Full Text] [Related]
18. Achieving effective and selective CK1 inhibitors through structure modification.
Du C; Yang H; Feng F; Liu W; Chen Y; Sun H
Future Med Chem; 2021 Mar; 13(5):505-528. PubMed ID: 33438471
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Potent and Exquisitely Selective Inhibitors of Kinase CK1 with Tunable Isoform Selectivity.
Němec V; Khirsariya P; Janovská P; Moyano PM; Maier L; Procházková P; Kebková P; Gybel' T; Berger BT; Chaikuad A; Reinecke M; Kuster B; Knapp S; Bryja V; Paruch K
Angew Chem Int Ed Engl; 2023 Mar; 62(11):e202217532. PubMed ID: 36625768
[TBL] [Abstract][Full Text] [Related]
20. 2-Phenylamino-6-cyano-1H-benzimidazole-based isoform selective casein kinase 1 gamma (CK1γ) inhibitors.
Hua Z; Huang X; Bregman H; Chakka N; DiMauro EF; Doherty EM; Goldstein J; Gunaydin H; Huang H; Mercede S; Newcomb J; Patel VF; Turci SM; Yan J; Wilson C; Martin MW
Bioorg Med Chem Lett; 2012 Sep; 22(17):5392-5. PubMed ID: 22877629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
